Las Condes

264 / 320

668
REFERENCIAS BIBLIOGRÁFICAS
1. Shah, B. M., & Hajjar, E. R. (2012). Polypharmacy, Adverse
Drug Reactions, and Geriatric Syndromes. Clinics in Geriatric
Medicine, 28(2), 173–186.
cger.2012.01.002.
2. Sera, L. C., & McPherson, M. L. (2012). Pharmacokinetics
and Pharmacodynamic Changes Associated with Aging
and Implications for Drug Therapy. Clinics in Geriatric
Medicine, 28(2), 273–286.
cger.2012.01.007.
3. Hanlon, J. T., Pieper, C. F., Hajjar, E. R., Sloane, R. J., Lindblad,
C. I., Ruby, C. M., & Schmader, K. E. (2006). Incidence and
predictors of all and preventable adverse drug reactions
in frail elderly persons after hospital stay. The Journals
of Gerontology Series a: Biological Sciences and Medical
Sciences, 61(5), 511–515.
4. Klarin, I., Wimo, A., & Fastbom, J. (2005). The association of
inappropriate drug use with hospitalisation and mortality: a
population-based study of the very old. Drugs & Aging, 22(1),
69–82.
5. Alhawassi, T., Bajorek, B., & Krass, I. (2014). A systematic
review of the prevalence and risk factors for adverse drug
reactions in the elderly in the acute care setting. Clinical
Interventions in Aging, 2079–8.
S71178.
6. Cahir, C., Bennett, K., Teljeur, C., & Fahey, T. (2013). Potentially
inappropriate prescribing and adverse health outcomes in
community dwelling older patients. British Journal of Clinical
Pharmacology, 77(1), 201–210.
bcp.12161.
7. Fried, T. R., O’Leary, J., Towle, V., Goldstein, M. K., Trentalange,
M., & Martin, D. K. (2014). Health Outcomes Associated
with Polypharmacy in Community-Dwelling Older Adults: A
Systematic Review. Journal of the American Geriatrics Society,
62(12), 2261–2272.
8. Mannesse, C. K., Derkx, F. H., de Ridder, M. A., Veld, A. J. M.
I.‘., & van der Cammen, T. J. (2000). Contribution of adverse
drug reactions to hospital admission of older patients.
Age and Ageing, 29(1), 35–39.
ageing/29.1.35.
9. Franceschi, M., Scarcelli, C., Niro, V., Seripa, D., Pazienza, A.
M., Pepe, G., et al. (2008). Prevalence, clinical features and
avoidability of adverse drug reactions as cause of admission
to a geriatric unit: a prospective study of 1756 patients. Drug
Safety, 31(6), 545–556.
10. O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M. N., Ryan,
C., & Gallagher, P. (2015). STOPP/START criteria for potentially
inappropriate prescribing in older people: version 2. Age and
Los autores declaran no tener conflictos de interés, en relación a este artículo.
Ageing, 44(2), 213–218.
afu145.
11. Arriagada L (2008) Uso de Medicamentos en el Adulto Mayor
Rev Hosp Clin Univ Chile, 19, 309-317.
12. Stahlmann, R., & Lode, H. (2010). Safety Considerations
of Fluoroquinolones in the Elderly. Drugs & Aging,
27(3), 193–209.
000000000-00000.
13. Schmucker, D. L. (2001). Liver function and phase I drug
metabolism in the elderly: a paradox. Drugs & Aging, 18(11),
837–851.
14. Cumming R, Le Couteur D. Benzodiazepines and Risk of Hip
Fractures in Older People. CNS Drugs. 2003; 17(11): 825-837
15. Eldesoky E. Pharmacokinetic-Pharmacodynamic Crisis in the
Elderly. American Journal of Therapeutics. 2007;14,488-
498).
16. Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C,
Tzourio C, et al. Inappropriate drug use and mortality in
community-dwelling elderly with impaired kidney function
– the Three-City population-based study. Nephrol Dial
Transplant. 2011;26(9):2852-9.
17. Garg A, Papaioannou A, Ferko N, Campbell G, Clarke J, Ray
J. Estimating the prevalence of renal insufficiency in seniors
requiring long-term care. Kidney Int. 2004; 65(2):649.
18. Field, T. S., Mazor, K. M., Briesacher, B., DeBellis, K. R., &
Gurwitz, J. H. (2007). Adverse Drug Events Resulting from
Patient Errors in Older Adults. Journal of the American
Geriatrics Society, 55(2), 271–276.
11/j.1532-5415.2007.01047.
19. Field, T. S., Gurwitz, J. H., Avorn, J., McCormick, D., Jain,
S., Eckler, M., et al. (2001). Risk Factors for Adverse Drug
Events Among Nursing Home Residents. Archives of Internal
Medicine, 161(13), 1629–1634.
archinte.161.13.1629.
20 Davies, E. A., & O’Mahony, M. S. (2015). Adverse drug reactions
in special populations - the elderly. British Journal of Clinical
Pharmacology, 80(4), 796–807.
bcp.12596.
21. Ferreira M et al. (2012). Polifarmácia entre idosos do
Município de São Paulo - Estudo SABE. Revista Brasileira De
Epidemiologia, 15(4), 817–827.
S1415-790X2012000400013.
22. Gokula, M., & Holmes, H. M. (2012). Tools to Reduce
Polypharmacy. Clinics in Geriatric Medicine, 28(2), 323–341.
23. Anderson, G. F. (2005). Medicare and chronic conditions. The
New England Journal of Medicine, 353(3), 305–309. http://
[REV. MED. CLIN. CONDES - 2016; 27(5) 660-670]